All media were prepared as reported previously57 (link). Advanced Dulbecco’s modified Eagle’s medium (DMEM)–F-12 medium supplemented with 1× GlutaMAX (Gibco), 10 mM HEPES (Sigma-Aldrich), and 100 Units/ml penicillin-streptomycin (Sigma-Aldrich) was used as the basal medium. Expansion medium (EM) is basal medium supplemented with 50% (vol/vol) Wnt3A-conditioned medium, 20% (vol/vol) R-spondin-1-conditioned medium, 10% (vol/vol) Noggin-conditioned medium, 1× B27 supplement (Gibco), 1 mM N-acetylcysteine (Sigma), 1× Primocin (InvivoGen), 50 ng/ml human epidermal growth factor (R&D Systems), 10 nM [Leu-15]-gastrin (AnaSpec), 500 nM A83-01 (Tocris), and 10 μM SB202190 (Tocris). Differentiation medium is comprised of basal medium (no penicillin-streptomycin added), 10% (vol/vol) Noggin-conditioned medium, 1 mM N-acetylcysteine (Sigma), 50 ng/ml human epidermal growth factor (R&D Systems), 10 nM [Leu-15]-gastrin (AnaSpec), 500 nM A83-01 (Tocris), and 10% fetal bovine serum (Sigma Aldrich). Wnt3A (American Type Culture Collection, Manassas, VA), R-spondin1 (kindly provided by Dr. Calvin Kuo, Stanford University, Stanford, CA), and Noggin58 (link) (kindly provided by Dr. Marcel Bijvelds, Erasmus University, Rotterdam, the Netherlands) cell lines were maintained to produce conditioned media.
Free full text: Click here